,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-06-19 05:30:00,"Chicago, IL - June 19, 2017 - Zacks.com announces the list of stocks featured in the Analyst Blog.",0.018081655725836754,0.008658703416585922,0.973259687423706,neutral,0.009422952309250832
1,2017-06-19 05:30:00,Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.,0.021041298285126686,0.011407552286982536,0.9675511121749878,neutral,0.00963374599814415
2,2017-06-19 05:30:00,"Stocks recently featured in the blog include Apple (NASDAQ: AAPL- Free Report ), Procter & Gamble (NYSE: PG- Free Report ), Celgene (NASDAQ: CELG- Free Report ), PayPal (NASDAQ: PYPL- Free Report ) and Southern Company (NYSE: SO- Free Report ).",0.026273313909769058,0.011089552193880081,0.962637186050415,neutral,0.015183761715888977
3,2017-06-19 05:30:00,"Today, Zacks is promoting its ''Buy'' stock recommendations.",0.3684377670288086,0.010614300146698952,0.6209479570388794,neutral,0.3578234612941742
4,2017-06-19 05:30:00,Get #1Stock of the Day pick for free.,0.0864095613360405,0.03249066323041916,0.8810997605323792,neutral,0.05391889810562134
5,2017-06-19 05:30:00,"Here are highlights from Friday's Analyst Blog:

The Zacks Research Daily presents the best research output of our analyst team.",0.2284756302833557,0.009567669592797756,0.7619567513465881,neutral,0.21890796720981598
6,2017-06-19 05:30:00,"Today's Research Daily features new research reports on 16 major stocks, including Apple (NASDAQ: AAPL- Free Report ), Procter & Gamble (NYSE: PG- Free Report ) and Celgene (NASDAQ: CELG- Free Report ).These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.",0.09994272142648697,0.007146518677473068,0.8929107189178467,neutral,0.0927962064743042
7,2017-06-19 05:30:00,"You can see all oftoday's research reports here >>>

Apple shares are up +24.1% in the year-to-date period, handily outperforming the S&P 500 (up +9%) and the Zacks Technology sector (up +14.2%), with each of the last two earnings releases adding to the stock's momentum.",0.9339870810508728,0.03752899542450905,0.028483854606747627,positive,0.896458089351654
8,2017-06-19 05:30:00,"In the updated research report issued today, the Zacks analyst points out that Apple's fortunes are tied to its flagship offering, the iPhone, at least in the near term.",0.5640940070152283,0.013356807641685009,0.42254918813705444,positive,0.550737202167511
9,2017-06-19 05:30:00,"The buzz surrounding iPhone 8, which is already labeled a super cycle, should allay investors fear about iPhone sales trajectory.",0.764509916305542,0.08292952179908752,0.1525605022907257,positive,0.6815804243087769
10,2017-06-19 05:30:00,"Also, the company announced an increase in the share repurchase authorization by $50 billion, taking total authorization to $300 million.",0.9124688506126404,0.014598232693970203,0.07293295115232468,positive,0.8978706002235413
11,2017-06-19 05:30:00,Apple raised its quarterly dividend by 10.5%.,0.9363126754760742,0.021935490891337395,0.04175187647342682,positive,0.9143772125244141
12,2017-06-19 05:30:00,"However, macroeconomic headwinds in some key regions like China and increasing competition remain concerns.",0.08845358341932297,0.6501903533935547,0.26135608553886414,negative,-0.5617367625236511
13,2017-06-19 05:30:00,(You can read the full research report on Apple here >>> ) .,0.016617102548480034,0.01596282795071602,0.9674201011657715,neutral,0.0006542745977640152
14,2017-06-19 05:30:00,Shares of Procter & Gamble outperformed the Zacks Consumer Staples sector in the past year (+7.7% vs. +5.9%).,0.7148777842521667,0.2644777297973633,0.020644474774599075,positive,0.45040005445480347
15,2017-06-19 05:30:00,"However, P&G shares have underperformed the S&P 500 index in the year-to-date period (up +6.5% vs. +9%).",0.24532832205295563,0.7356969118118286,0.018974747508764267,negative,-0.4903686046600342
16,2017-06-19 05:30:00,The company has been struggling to boost market growth for the last few quarters.,0.04908083751797676,0.9198678731918335,0.03105132281780243,negative,-0.8707870244979858
17,2017-06-19 05:30:00,"Also, significant negative forex impact has been hurting sales.",0.021304726600646973,0.9656021595001221,0.013093190267682076,negative,-0.9442974328994751
18,2017-06-19 05:30:00,But the Zacks analyst likes the fact that P&G is speeding up innovations and investments to counter softening industry growth.,0.8218693733215332,0.017717216163873672,0.16041336953639984,positive,0.8041521310806274
19,2017-06-19 05:30:00,Its productivity improvements and aggressive cost-saving efforts are also consistently helping to boost profit levels.,0.955689013004303,0.019098646938800812,0.025212347507476807,positive,0.9365903735160828
20,2017-06-19 05:30:00,(You can read the full research report on Procter & Gamble here >>> ) .,0.013788774609565735,0.010992237366735935,0.9752189517021179,neutral,0.0027965372428297997
21,2017-06-19 05:30:00,"Celgene 's shares have gained +4.6% year to date, outperforming the Zacks Medical - Biomedical and Genetics sector which has gained +2.5% over the same period.",0.9567160606384277,0.025350093841552734,0.01793382316827774,positive,0.931365966796875
22,2017-06-19 05:30:00,Celgene's multiple myeloma drug Revlimid continues to grow on the back of market share gains and increased duration.,0.9531962871551514,0.017045488581061363,0.029758239164948463,positive,0.9361507892608643
23,2017-06-19 05:30:00,"However, Otezla sales in the first quarter were impacted by managed care dynamics that drove lower total marketplace prescriptions for psoriasis therapies.",0.018380936235189438,0.9625738859176636,0.019045108929276466,negative,-0.9441929459571838
24,2017-06-19 05:30:00,The Zacks analyst likes Celgene's ongoing label expansion efforts and pipeline development.,0.6795211434364319,0.014330594800412655,0.3061482608318329,positive,0.665190577507019
25,2017-06-19 05:30:00,The company anticipates several pipeline-related events over the upcoming quarters and next few years.,0.034515466541051865,0.010354015044867992,0.9551305770874023,neutral,0.024161450564861298
26,2017-06-19 05:30:00,(You can read the full research report on Celgene here >>> ) .,0.013327891938388348,0.011790039017796516,0.9748821258544922,neutral,0.0015378529205918312
27,2017-06-19 05:30:00,Other noteworthy reports we are featuring today include PayPal (NASDAQ: PYPL- Free Report ) and Southern Company (NYSE: SO- Free Report ).,0.03652031719684601,0.0060849497094750404,0.9573946595191956,neutral,0.030435368418693542
28,2017-06-19 05:30:00,Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007?,0.08660752326250076,0.09298931062221527,0.8204032182693481,neutral,-0.006381787359714508
29,2017-06-19 05:30:00,Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market.,0.8251555562019348,0.016993124037981033,0.15785132348537445,positive,0.8081624507904053
30,2017-06-19 05:30:00,Demand could soar from almost nothing to $42 billion by 2025.,0.8458088040351868,0.019966978579759598,0.13422414660453796,positive,0.8258418440818787
31,2017-06-19 05:30:00,"Reports suggest it could save 10 million lives per decade, which could in turn save $200 billion in U.S. healthcare costs.",0.6522005200386047,0.12595504522323608,0.2218443602323532,positive,0.5262454748153687
32,2017-06-19 05:30:00,A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it.,0.5342763066291809,0.015187621116638184,0.4505361020565033,positive,0.5190886855125427
33,2017-06-19 05:30:00,"Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.",0.8605390787124634,0.019841492176055908,0.11961936950683594,positive,0.8406975865364075
34,2017-06-19 05:30:00,"Click to see them right now >>

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar.",0.06344151496887207,0.47883740067481995,0.4577210545539856,negative,-0.4153958857059479
35,2017-06-19 05:30:00,They're virtually unknown to the general public.,0.035764459520578384,0.0785161554813385,0.885719358921051,neutral,-0.04275169596076012
36,2017-06-19 05:30:00,"Yet today's 220 Zacks Rank #1 ""Strong Buys"" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015.",0.6580293774604797,0.017276067286729813,0.32469451427459717,positive,0.6407533288002014
37,2017-06-19 05:30:00,Its average gain has been a stellar +26% per year.,0.8422174453735352,0.0191669799387455,0.13861553370952606,positive,0.8230504393577576
38,2017-06-19 05:30:00,See these high-potential stocks free >>.,0.12527841329574585,0.05778927728533745,0.8169323205947876,neutral,0.0674891322851181
39,2017-06-19 05:30:00,"Get the full Report on AAPL - FREE

Get the full Report on PG - FREE

Get the full Report on CELG - FREE

Get the full Report on PYPL - FREE

Get the full Report on SO - FREE

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.",0.013315657153725624,0.00898862536996603,0.9776957631111145,neutral,0.004327031783759594
40,2017-06-19 05:30:00,Past performance is no guarantee of future results.,0.023727279156446457,0.008731111884117126,0.9675416350364685,neutral,0.01499616727232933
41,2017-06-19 05:30:00,Inherent in any investment is the potential for loss.,0.023265572264790535,0.09617827832698822,0.8805561661720276,neutral,-0.07291270792484283
42,2017-06-19 05:30:00,"This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.",0.011962415650486946,0.010706594213843346,0.9773310422897339,neutral,0.0012558214366436005
43,2017-06-19 05:30:00,No recommendation or advice is being given as to whether any investment is suitable for a particular investor.,0.01822577603161335,0.008984367363154888,0.9727898240089417,neutral,0.009241408668458462
44,2017-06-19 05:30:00,"It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.",0.020858757197856903,0.007662615738809109,0.9714785814285278,neutral,0.013196141459047794
45,2017-06-19 05:30:00,All information is current as of the date of herein and is subject to change without notice.,0.01124907098710537,0.013303965330123901,0.9754469990730286,neutral,-0.002054894343018532
46,2017-06-19 05:30:00,Any views or opinions expressed may not reflect those of the firm as a whole.,0.008276145905256271,0.021656149998307228,0.9700676798820496,neutral,-0.013380004093050957
47,2017-06-19 05:30:00,"Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities.",0.009504852816462517,0.012596068903803825,0.9778990745544434,neutral,-0.0030912160873413086
48,2017-06-19 05:30:00,These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.,0.14585068821907043,0.02033580094575882,0.8338135480880737,neutral,0.1255148947238922
49,2017-06-19 05:30:00,These are not the returns of actual portfolios of stocks.,0.010538044385612011,0.012450686655938625,0.9770112633705139,neutral,-0.0019126422703266144
50,2017-06-19 05:30:00,The S&P 500 is an unmanaged index.,0.022511588409543037,0.0801919475197792,0.8972964882850647,neutral,-0.05768036097288132
51,2017-06-19 05:30:00,Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.,0.01078665629029274,0.015373211354017258,0.9738401174545288,neutral,-0.004586555063724518
52,2017-06-19 05:30:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
53,2017-06-19 05:30:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
54,2017-06-19 05:30:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
55,2017-06-19 05:30:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.015637893229722977,0.9741575717926025,neutral,-0.0054333265870809555
